Dr. Markus Jorger, MD
Claim this profileKantonsspital St. Gallen
Studies Lung Cancer
Studies Soft Tissue Sarcoma
1 reported clinical trial
1 drug studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
2Soft Tissue Sarcoma
Stage IV
Stage III
More about Markus Jorger, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Markus Jorger, MD has experience with
- IP-001
Breakdown of trials Markus Jorger, MD has run
Soft Tissue Sarcoma
Non-Small Cell Lung Cancer
Metastatic Tumor
Colon Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Markus Jorger, MD specialize in?
Markus Jorger, MD focuses on Lung Cancer and Soft Tissue Sarcoma. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Markus Jorger, MD currently recruiting for clinical trials?
No, Markus Jorger, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Markus Jorger, MD has studied deeply?
Yes, Markus Jorger, MD has studied treatments such as IP-001.
What is the best way to schedule an appointment with Markus Jorger, MD?
Apply for one of the trials that Markus Jorger, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.